Skip to main content
Sonoma Pharmaceuticals, Inc. logo

Sonoma Pharmaceuticals, Inc. — Investor Relations & Filings

Ticker · SNOA ISIN · US83558L2043 US Manufacturing
Open in API
Filings indexed 951 across all filing types
Latest filing 2015-01-22 Capital/Financing Update
Country US United States of America
Listing US SNOA

About Sonoma Pharmaceuticals, Inc.

https://sonomapharma.com/

Sonoma Pharmaceuticals, Inc. is a specialty pharmaceutical company that develops and commercializes products based on its patented Microcyn® Technology, a stabilized hypochlorous acid (HOCl) platform. With over 20 years of experience, the company produces a range of prescription and over-the-counter solutions for advanced wound care, dermatology, animal health, and eye care. Its products are designed to manage various conditions by promoting healing and reducing the risk of infection. The portfolio serves healthcare professionals in settings like hospitals and nursing homes, as well as consumers for at-home use.

Recent filings

Filing Released Lang Actions
PROSPECTUS
Capital/Financing Update Classification · 100% confidence The document is a detailed prospectus filed pursuant to Rule 424(b)(2) for Oculus Innovative Sciences, Inc. It describes an offering of common stock and warrants, including pricing, underwriting details, use of proceeds, risk factors, and summary financial information. The document is a registration and offering prospectus related to capital raising activities, not a financial report, earnings release, or management discussion. It is not an announcement of a report but the actual offering document. This fits the category of Capital/Financing Update (CAP), which covers updates on company fundraising and financing activities.
2015-01-22 English
Regulatory Filings 2015
Regulatory Filings
2015-01-21 English
AMENDMENT NO. 4
Capital/Financing Update Classification · 100% confidence The document is titled 'Amendment No. 4 to the FORM S-1 Registration Statement' filed with the SEC. It is a registration statement under the Securities Act of 1933 for Oculus Innovative Sciences, Inc. The text includes detailed information about the securities being registered, offering price, underwriting, and use of proceeds. It is a filing related to the company's initial public offering or securities offering registration, not a financial report, earnings release, or management discussion. The S-1 form is a registration statement for securities offerings, which falls under Capital/Financing Update filings as it relates to fundraising and capital structure changes. The document is lengthy (15,000 characters) and contains substantive offering details, not just an announcement or certification. Therefore, the appropriate classification is Capital/Financing Update (CAP).
2015-01-20 English
AUTO-GENERATED PAPER DOCUMENT
Regulatory Filings
2015-01-16 English
AMENDMENT NO. 3
Capital/Financing Update Classification · 100% confidence The document is an Amendment No. 3 to a Form S-1 Registration Statement filed with the SEC. It includes detailed information about the securities being registered, the offering, underwriting, risk factors, business description, management, and financial statements. The Form S-1 is a registration statement used for initial public offerings or other securities offerings. This document is not an annual report, earnings release, or any other financial report but a capital markets filing related to a securities offering. Therefore, it fits the category of Capital/Financing Update (CAP). The document length is substantial (15,000 characters), and it contains the full registration statement text, not just an announcement or certification, confirming it is a primary filing of a securities offering.
2015-01-16 English
FORM 8-A
Regulatory Filings Classification · 100% confidence The document is a Form 8-A filed with the SEC for the registration of certain classes of securities pursuant to Section 12(b) or 12(g) of the Securities Exchange Act of 1934. It includes descriptions of securities to be registered, references to other filings, and exhibits related to the registration. There are no financial statements, earnings data, or management discussion. The document is a regulatory filing related to securities registration, not a financial report, earnings release, or other specific report type. Therefore, it fits best under Regulatory Filings (RNS). The document length is 8940 characters, which is substantive but the content is clearly a registration form, not a report or announcement of a report publication.
2015-01-16 English

Browse filings by year

21 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.